Gain-of-function mutations in RHBDF2, the gene encoding iRHOM2, underlie Tylosis with Oesophageal Cancer (TOC)5, a syndrome characterised by palmoplantar epidermis thickening. The gene discussed is RHBDF2; the disease is Non-epidermolytic palmoplantar keratoderma.